Contact us at 1.800.501.7654 or info@biossusa.com
Browse research updates, product guides, grant news, and practical antibody workflow articles from Bioss.
Before your body produces specific antibodies against a new invader, a powerful defense system is already hard at work. Meet the complement system— one of the immune system’s fastest and most sophisticated weapons. This ancient cascade of proteins can detect, tag, and...
Read more
Rabbit-derived antibodies offer superior affinity, broader epitope recognition, and enhanced stability due to unique immune system features like gene conversion and high somatic hypermutation rates—making them powerful tools for diagnostics and therapeutics.
Read more
The story of bispecific antibodies teaches us that biomedical innovation often stems from deep understanding and creative adaptation of natural mechanisms. Just as the immune system itself is a masterful "multispecific" recognition network, scientists have mimicked and expanded upon it to unlock...
Read more
Research-grade in vivo biosimilar antibodies provide a critical tool for scientists studying therapeutic mechanisms in disease models. Their high demand is fueled by the rapid growth of biopharmaceutical research, the need for cost-effective alternatives to commercial antibodies, and the expansion of immuno-oncology,...
Read more
Bioss is supporting National Immunizaiton Awareness Month with a research grant! Submissions are open for relevant research projects and educational utilization. See terms and conditions for more information.
Read moreThe Power of CAR-T Cell Therapy: Revolutionizing Cancer Treatment
Read more
making cancer cells as the antigen-presenting cells
Read more
Consider Using Labeled Primary Antibodies for Multiplexing
Read moreUsing Bioss B1R and B2R antibodies, researchers from the University of Houston, Texas, and Tongji University School of Medicine, Shanghai, investigated whether antagonism of the bradykinin receptor B1R ameliorated lupus nephritis.
Read more
Dry eyes can become a serious medical concern resulting in major quality of life concerns and, in severe cases, partial or full loss of vision. New research using Bioss antibodies indicates a potential new therapy for dry eyes, which is now in...
Read more
